Global Transcriptomics Technologies Market to Reach $4.62 Billion by 2019, Driven by Rising Demand for Personalized Medicine

The global transcriptomics technologies market is poised for remarkable growth in the coming years, driven by the rising demand for personalized and targeted therapeutics. Pharmaceutical companies are increasingly focusing on developing disease-specific biomarkers, which is fueling the demand for transcriptomics technologies. Additionally, significant investments in research and development, coupled with improvements in healthcare infrastructure, are providing a substantial boost to the growth of this market. As bioinformatics tools evolve and become more sophisticated, the market is expected to experience further expansion, attracting both software and life science companies. The global market opportunity, valued at US$2.55 billion in 2015, is projected to grow at a compound annual growth rate (CAGR) of 15.9%, reaching US$4.62 billion by 2019.

Explore the highlights and essential data from our Report in this sample - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1659

Market Size and Growth

The global transcriptomics technologies market is witnessing substantial growth, driven by advances in genomics, proteomics, and bioinformatics. With an opportunity of US$2.55 billion in 2015, the market is expanding at a healthy CAGR of 15.9% and is expected to surpass US$4.62 billion by 2019. This growth trajectory can be attributed to several factors, including increased demand for personalized medicine, the proliferation of research activities, and continuous technological innovations in transcriptomics technologies.

Competitive Landscape

The transcriptomics technologies market is highly competitive, with key players leading the industry in technological innovation and market share. Leading companies include Affymetrix Inc., Agilent Technologies, F-Hoffmann La Roche Ltd., Illumina Inc., Life Technologies Corporation, and Thermo Fisher Scientific. These companies have made substantial investments in R&D, allowing them to offer cutting-edge transcriptomics technologies to research institutes, biotech companies, and pharmaceutical firms. The competition is also fueled by a growing demand for efficient, high-quality transcriptomics solutions, leading to product innovations and strategic collaborations in the market.

Market Segmentation

The transcriptomics technologies market is segmented by technology, application, and region.

By Technology:

Polymerase Chain Reaction (PCR): PCR continues to dominate the market due to its high process efficiency, precision, and amplification capabilities. This segment is poised for steady growth, as PCR finds applications across multiple domains, including drug discovery and diagnostics.

Next-Generation Sequencing (NGS): The NGS segment is expected to witness the fastest growth, with a CAGR greater than 19.0% during the forecast period. Technological advancements and the ability to analyze the transcriptome from various perspectives are driving NGS's increasing adoption in research and clinical settings.

By Application:

Drug Discovery and Research: The drug discovery and research segment is the dominant revenue generator in the market, supported by extensive research in genomics and proteomics. The segment is anticipated to expand at a significant CAGR of 18.2% during the forecast period, driven by continuous advancements in drug development and the need for transcriptomics technologies in identifying disease-specific biomarkers.

Review our report to gain deeper insights and understanding - https://www.transparencymarketresearch.com/transcriptomics-technologies-market.html

Regional Analysis

The global transcriptomics technologies market is geographically diverse, with North America leading in market share, followed by Asia Pacific, Europe, and the Rest of the World.

North America:

North America is expected to dominate the market, accounting for approximately 39% of the total market revenue by 2019. The region's strong position is bolstered by a robust biotech industry, established infrastructure, and advanced technological platforms. Additionally, private investments in transcriptomics research and the presence of several leading academic and research institutions contribute to North America's dominance. These factors drive the development of targeted therapeutics and the continued growth of the market.

Asia Pacific:

The Asia Pacific region is poised to experience the highest growth rate, with a projected CAGR of 18.0% during the forecast period. The growth is primarily driven by the increasing research and development activities in life sciences and the growing trend of outsourcing clinical research, particularly in countries like India and China. The expanding infrastructure and government support for research initiatives also play a crucial role in propelling the transcriptomics technologies market in the region.

Europe and Rest of the World:

Both Europe and the Rest of the World are expected to experience moderate growth during the forecast period. Europe's growth will be driven by the increasing number of research collaborations and rising investments in the life sciences sector. In the Rest of the World, emerging markets are investing in healthcare and research, which will contribute to the market's growth.

Future Outlook

The global transcriptomics technologies market is expected to continue its upward trajectory, driven by the increasing demand for personalized medicine, the advancement of research and development, and technological innovations in transcriptomics. The rising use of next-generation sequencing (NGS) technologies and the integration of bioinformatics tools are likely to be key drivers in the future. Furthermore, as more biotech firms, academic institutions, and pharmaceutical companies invest in transcriptomics research, the market is set to experience considerable expansion.

More Trending Reports by Transparency Market Research –

Lung Cancer Diagnostics Market - Projected to grow at a CAGR of 7.9% from 2024 to 2034 and reach more than US$ 34.8 Bn by the end of 2034.

Metabolomics Market - Projected to advance at a CAGR of 12.3% from 2024 to 2034 and reach more than US$ 9.5 Bn by the end of 2034.

About Transparency Market Research

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact:

Transparency Market Research Inc.

CORPORATE HEADQUARTER DOWNTOWN,

1000 N. West Street,

Suite 1200, Wilmington, Delaware 19801 USA

Tel: +1-518-618-1030

USA – Canada Toll Free: 866-552-3453

Website: https://www.transparencymarketresearch.com    

Email: sales@transparencymarketresearch.com

Follow Us: LinkedIn| Twitter| Blog | YouTube